
Henan Taloph Pharmaceutical Stock Co.,Ltd
SSE:600222.SS
5.87 (CNY) • At close June 9, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Henan Taloph Pharmaceutical Stock Co.,Ltd |
Symbool | 600222.SS |
Munteenheid | CNY |
Prijs | 5.87 |
Beurswaarde | 3,245,665,054 |
Dividendpercentage | 0% |
52-weken bereik | 4.03 - 5.93 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jianchao Luo |
Website | https://www.taloph.com |
An error occurred while fetching data.
Over Henan Taloph Pharmaceutical Stock Co.,Ltd
Henan Taloph Pharmaceutical Stock Co., Ltd. researches, produces, and sells Chinese and western medicines in China. It primarily offers its products in the forms of oral liquids, tablets, capsules, fluids, and other forms. The company's principal products include Huperzine A tablets, phenoxybenzamine hydrochloride tablets, pazufloxacin mesylate sodium chloride injections, and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)